Multicenter phase II trial of docetaxel and carboplatin in patients with stage IIIB and IV non-small-cell lung cancer
Open Access
- 1 June 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 11 (6) , 673-678
- https://doi.org/10.1023/a:1008342116536
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results of an Eastern Cooperative Oncology Group TrialJournal of Clinical Oncology, 2000
- Docetaxel and Cisplatin in Patients with Advanced Non–Small-Cell Lung Cancer (NSCLC): A Multicenter Phase II TrialClinical Lung Cancer, 1999
- Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of LifeJournal of Clinical Oncology, 1999
- Phase I Trial, Including Pharmacokinetic and Pharmacodynamic Correlations, of Combination Paclitaxel and Carboplatin in Patients With Metastatic Non–Small-Cell Lung CancerJournal of Clinical Oncology, 1999
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Chemotherapy vs Supportive Care in Advanced Non-Small-Cell Lung CancerChest, 1994
- Chemotherapy of Lung CancerNew England Journal of Medicine, 1992
- Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum IICancer Chemotherapy and Pharmacology, 1982
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958